Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study.

PloS one - 1 Jan 2016

Alric Laurent, Besson Caroline, Lapidus Nathanael, Jeannel Juliette, Michot Jean-Marie, Cacoub Patrice, Canioni Danielle, Pol Stanislas, Davi Frédéric, Rabiega Pascaline, Ysebaert Loic, Bonnet Delphine, Hermine Olivier

Abstract excerpt

Hepatitis C virus (HCV) infection is associated with lymphoproliferative disorders and B-cell non-Hodgkin lymphomas (B-NHLs). Evaluation of the efficacy and safety profiles of different antiviral therapies in HCV patients with B-NHL is warranted. METHODS: First, we evaluated the sustained virologic response (SVR) and safety of Peg-interferon-alpha (Peg-IFN) + ribavirin +/- first protease inhibitors (PI1s) therapy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Interferon-alpha
Share to Lymphoma, B-Cell

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Lymphoma, B-Cell, Marginal Zone

Share to Lymphoma, Large B-Cell, Diffuse

Share to Polyethylene Glycols

Share to Proportional Hazards Models

Share to Protease Inhibitors

Share to Ribavirin

Source

Open in PubMed Open full text

Identifiers

PMID: 27749916
DOI: 10.1371/journal.pone.0162965
PMCID: PMC5066969

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study.PMID 27749916Read ↗

Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma.Semantic proximity Read ↗

Hepatitis C Virus-Associated B-Cell Non-Hodgkin's Lymphoma: Clinical and Therapeutic Challenges.Semantic proximity Read ↗

Hepatitis C Virus-Associated Non-Hodgkin Lymphomas: Biology, Epidemiology, and Treatment.Semantic proximity Read ↗

Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience.Semantic proximity Read ↗

Elbasvir/Grazoprevir combination therapy in a B-NHL patient with HCV genotype 1 infection.Semantic proximity Read ↗

Most patients with HCV-associated lymphoma present with mild liver disease: a call to revise antiviral treatment prioritization.Semantic proximity Read ↗

Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study.Semantic proximity Read ↗

Functional phenotypes and gene expression profiles of peripheral blood mononuclear cells in chronic hepatitis C patients who developed non-Hodgkin's B-cell lymphoma.Semantic proximity Read ↗

Molecular characterization of diffuse large B-cell lymphomas associated with hepatitis C virus infection.Semantic proximity Read ↗

Successful treatment by on-demand glecaprevir and pibrentasvir for hepatitis C flare during R-CHOP in patients with diffuse large B-cell lymphoma: a case report.Semantic proximity Read ↗

Hepatitis C virus in non-Hodgkin's lymphoma. A reappraisal after a prospective case-control study of 300 patients. Lombart Study Group of HCV-Lymphoma.Semantic proximity Read ↗

Hepatitis C Virus Infection and Risk of Non-Hodgkin’s Lymphoma: A Case-control Study in Mainland ChinaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.